Lis William 4
4 · Jasper Therapeutics, Inc. · Filed Mar 23, 2022
Insider Transaction Report
Form 4
Lis William
DirectorChief Executive Officer
Transactions
- Award
Voting Common Stock
2022-03-21+89,972→ 89,972 total - Award
Stock Option (right to buy)
2022-03-21+7,500→ 7,500 totalExercise: $3.54Exp: 2032-03-21→ Voting Common Stock (7,500 underlying) - Award
Stock Option (right to buy)
2022-03-21+89,972→ 89,972 totalExercise: $3.54Exp: 2032-03-21→ Voting Common Stock (89,972 underlying) - Award
Stock Option (right to buy)
2022-03-21+100,000→ 100,000 totalExercise: $3.54Exp: 2032-03-21→ Voting Common Stock (100,000 underlying)
Footnotes (4)
- [F1]The reported securities are represented by restricted stock units, 1/2 of which shall vest on each of June 24, 2022 and June 27, 2022, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
- [F2]1/4th of the shares subject to the option shall vest on December 7, 2022, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
- [F3]1/4th of the shares subject to the option vested on March 21, 2022, and 1/4th of the shares subject to the option shall vest on each of March 24, 2022, September 24, 2022 and March 24, 2023, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
- [F4]1/12th of the shares subject to the option shall vest on April 15, 2022, and 1/12th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive